A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients

Hepatitis A virus (HAV) is able to cause a spectrum of illnesses ranging from no symptom to fulminant hepatitis which may lead to acute kidney injury. Although hepatitis A vaccine is recommended in non-immune solid organ transplant recipients who live in or travel to endemic areas, the standard 2-do...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasoppokakorn, Thaninee, Vanichanan, Jakapat, Chaiteerakij, Roongruedee, Jutivorakool, Kamonwan, Udomkarnjananun, Suwasin, Pongpirul, Krit, Taesombat, Wipusit, Wattanatorn, Salin, Avihingsanon, Yingyos, Tungsanga, Kriang, Eiam-Ong, Somchai, Praditpornsilpa, Kearkiat, Townamchai, Natavudh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794436/
https://www.ncbi.nlm.nih.gov/pubmed/33420114
http://dx.doi.org/10.1038/s41598-020-80052-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794436/
https://www.ncbi.nlm.nih.gov/pubmed/33420114
http://dx.doi.org/10.1038/s41598-020-80052-3

Ejemplares similares